74 results
Page 3 of 4
S-3
jpn9wsp5t1nbtjmv99wl
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
3mlu8bq
5 Jan 22
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
2:22pm
8-K/A
EX-99.1
oa1rzm4z69z
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.3
uhjt20rs
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.2
g6g7hdv qjcn
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
f8ix358
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
ir0n 5gvsxd8mf7zxy
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
2jw62nt
24 Sep 21
Annual report
7:31am
10-K
ua4m5
24 Sep 21
Annual report
7:31am
424B3
muka704jmewd84yzvo
22 Jul 21
Prospectus supplement
10:27am
424B3
toxzrud5
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
n9uik0u0c0r5
19 Jan 21
Regulation FD Disclosure
2:42pm
10-Q
imvfo9dh
17 Dec 20
Quarterly report
12:00am